A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease

Full Title

A Phase Ib Trial of SX-682 (CXCR1/2 inhibitor) Combined with Proton Craniospinal Irradiation for Patients with Leptomeningeal Disease

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Komal Jhaveri’s office at 646-888-5108.

Protocol
26-263
Phase
Phase I (phase 1)
Investigator
Monica F. Chen
Co-Investigators
Yao Yu
Diseases
Lung Cancer › Lung Cancer, Non-Small Cell
Melanoma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07814352
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description